- Home
- VICR vs AGIO Comparison
VICR vs AGIO Comparison
Compare VICR & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VICR
- AGIO
- Stock Information
- Founded
- VICR 1981
- AGIO 2007
- Country
- VICR United States
- AGIO United States
- Employees
- VICR N/A
- AGIO N/A
- Industry
- VICR Industrial Machinery/Components
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- VICR Technology
- AGIO Health Care
- Exchange
- VICR Nasdaq
- AGIO Nasdaq
- Market Cap
- VICR 2.6B
- AGIO 2.4B
- IPO Year
- VICR N/A
- AGIO 2013
- Fundamental
- Price
- VICR $50.41
- AGIO $33.39
- Analyst Decision
- VICR Hold
- AGIO Buy
- Analyst Count
- VICR 2
- AGIO 7
- Target Price
- VICR $43.00
- AGIO $56.33
- AVG Volume (30 Days)
- VICR 216.3K
- AGIO 1.1M
- Earning Date
- VICR 02-20-2025
- AGIO 02-13-2025
- Dividend Yield
- VICR N/A
- AGIO N/A
- EPS Growth
- VICR N/A
- AGIO N/A
- EPS
- VICR 0.10
- AGIO 11.80
- Revenue
- VICR $355,544,000.00
- AGIO $32,871,000.00
- Revenue This Year
- VICR N/A
- AGIO $33.38
- Revenue Next Year
- VICR $10.70
- AGIO $163.06
- P/E Ratio
- VICR $514.07
- AGIO $2.92
- Revenue Growth
- VICR N/A
- AGIO 36.79
- 52 Week Low
- VICR $30.90
- AGIO $20.96
- 52 Week High
- VICR $61.05
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- VICR 46.17
- AGIO 27.95
- Support Level
- VICR $48.32
- AGIO $37.20
- Resistance Level
- VICR $52.27
- AGIO $44.46
- Average True Range (ATR)
- VICR 2.45
- AGIO 3.81
- MACD
- VICR -0.54
- AGIO -1.24
- Stochastic Oscillator
- VICR 29.45
- AGIO 3.54
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, advanced power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. Geographically, it derives a maximum of its revenue from the Asia Pacific.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.